Evaluation of MicroRNAs Regulating Anoikis Pathways and Its Therapeutic Potential

Sharan Malagobadan1, Noor Hasima Nagoor2

  • 1Institute of Biological Sciences (Genetics & Molecular Biology), Faculty of Science, University of Malaya, 50603 Kuala Lumpur, Malaysia.

Insights

MicroRNAs (miRNAs) are key regulators of cancer cell survival, particularly in anoikis resistance, which promotes metastasis. This review explores how specific miRNAs influence anoikis pathways, offering insights into new cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNA (miRNA) dysregulation is fundamental to cancer cell survival mechanisms.
  • Anoikis resistance, a key survival mechanism, enables cancer metastasis by preventing detachment-induced cell death.

Purpose of the Study:

  • To review the role of miRNAs in regulating anoikis pathways in cancer.
  • To identify miRNAs that promote anoikis sensitivity versus those that confer anoikis resistance.
  • To explore potential therapeutic strategies targeting miRNA-mediated anoikis regulation.

Main Methods:

  • Literature review of studies investigating miRNAs and anoikis.
  • Analysis of identified miRNAs promoting or inhibiting anoikis.
  • Examination of signaling pathways involved in miRNA-regulated anoikis.

Main Results:

  • Numerous miRNAs have been identified as critical in regulating anoikis.
  • Specific miRNAs can either sensitize cells to anoikis or promote resistance.
  • Understanding these miRNA roles provides a basis for novel therapeutic approaches.

Conclusions:

  • miRNAs are crucial regulators of anoikis, impacting cancer metastasis.
  • Targeting specific miRNAs offers a promising avenue for developing anti-cancer therapies.
  • Further research into miRNA-pathway interactions can refine therapeutic strategies.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
MicroRNAs01:22

MicroRNAs

12.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K